OptimizeRx
OPRX
85 hedge funds and large institutions have $95.5M invested in OptimizeRx in 2024 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 32 increasing their positions, 26 reducing their positions, and 16 closing their positions.
23% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 26
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4.06% less ownership
Funds ownership: 71.6% → 67.54% (-4.1%)
8% less funds holding
Funds holding: 92 → 85 (-7)
27% less capital invested
Capital invested by funds: $131M → $95.5M (-$35.3M)
38% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 16
95% less call options, than puts
Call options by funds: $7K | Put options by funds: $140K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Samjo Management
New York
|
+$2.36M |
| 2 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$1.06M |
| 3 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$933K |
| 4 |
AE
AMH Equity
Great Neck,
New York
|
+$889K |
| 5 |
BlackRock
New York
|
+$883K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
-$13.2M |
| 2 |
GIPM
G2 Investment Partners Management
New York
|
-$1.33M |
| 3 |
JP Morgan Chase
New York
|
-$931K |
| 4 |
Renaissance Technologies
New York
|
-$663K |
| 5 |
BFM
Boothbay Fund Management
New York
|
-$483K |
OPRX Hedge Fund Activity: Q3 2024 in Review
85 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in OptimizeRx (OPRX) for Q3 2024, worth a combined $95.5M — down 27% from $131M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of OPRX and 10 opened new positions — a net loss of 6 holders — while 26 trimmed existing stakes and 32 added.
The largest buyer was Samjo Management, adding an estimated $2.36M. The largest seller was Divisadero Street Capital Management, exiting entirely with an estimated $13.2M sold.
- 85 institutional investors held OptimizeRx (OPRX) as of Q3 2024, down from 92 in Q2 2024.
- Funds reported $95.5M of OptimizeRx stock for Q3 2024, down 27% quarter-over-quarter.
- 10 funds opened new OptimizeRx positions in Q3 2024 and 16 closed out, a net change of -6 holders.
- The largest OptimizeRx buyer in Q3 2024 was Samjo Management, an estimated $2.36M added.
- The largest OptimizeRx seller in Q3 2024 was Divisadero Street Capital Management, an estimated $13.2M sold.
Based on aggregated 13F filings for Q3 2024.